QuiVad
My list

Home / Japan / BrightPath Biotherapeutics Co.,Ltd.

BrightPath Biotherapeutics Co.,Ltd.

Short position disclosed on October 5, 2026.

Follow

Evolution of the disclosed total

0%2%4%6%
Aug 16Aug 29Sep 11Sep 24Oct 7
Sum of open short positions, as % of capital. Hover or tap the curve to see which funds make it up.

Open positions

The funds disclosing a short position that is still open.
FundTwelve months% of capitalOver the yearSince
Nomura International plc1.73%newOctober 5, 2026

Follow by RSS

Get the moves on BrightPath Biotherapeutics Co.,Ltd. by mail.

There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.

History of disclosures

55 disclosures on record for this share.
DateFund% of capitalEnd of publication
October 5, 2026Nomura International plc1.73%still open
September 30, 2026Nomura International plc1.84%
September 29, 2026Morgan Stanley & Co. International plc0.43%
September 28, 2026Nomura International plc2.11%
September 28, 2026JPM Securities Japan Co Ltd.0.74%
September 28, 2026Morgan Stanley & Co. International plc0.50%
September 18, 2026Nomura International plc1.72%
September 18, 2026Barclays Capital Securities Ltd1.09%
September 17, 2026Nomura International plc2.07%
September 17, 2026JPM Securities Japan Co Ltd.0.87%
September 16, 2026Nomura International plc1.99%
September 16, 2026Barclays Capital Securities Ltd1.11%
September 16, 2026JPM Securities Japan Co Ltd.0.99%
September 15, 2026Morgan Stanley & Co. International plc0.41%
September 14, 2026Nomura International plc1.76%
September 14, 2026Barclays Capital Securities Ltd1.09%
September 14, 2026Morgan Stanley & Co. International plc0.52%
September 11, 2026Morgan Stanley & Co. International plc0.46%
September 9, 2026Nomura International plc1.89%
September 9, 2026Barclays Capital Securities Ltd1.14%
September 9, 2026Morgan Stanley & Co. International plc0.55%
September 8, 2026Nomura International plc2.25%
September 8, 2026Barclays Capital Securities Ltd1.79%
September 4, 2026Nomura International plc2.07%
September 4, 2026Barclays Capital Securities Ltd1.53%
September 3, 2026Nomura International plc2.34%
September 2, 2026Nomura International plc2.50%
September 2, 2026JPM Securities Japan Co Ltd.1.09%
September 1, 2026Nomura International plc2.36%
September 1, 2026Barclays Capital Securities Ltd1.33%
August 26, 2026Nomura International plc2.47%
August 26, 2026JPM Securities Japan Co Ltd.1.18%
August 25, 2026Barclays Capital Securities Ltd1.25%
August 24, 2026Barclays Capital Securities Ltd1.30%
August 21, 2026Nomura International plc2.52%
August 20, 2026Nomura International plc2.45%
August 20, 2026JPM Securities Japan Co Ltd.1.25%
August 19, 2026Nomura International plc2.72%
August 17, 2026Nomura International plc2.53%
August 17, 2026JPM Securities Japan Co Ltd.1.37%
August 17, 2026Barclays Capital Securities Ltd1.23%
August 14, 2026Nomura International plc2.61%
August 14, 2026Barclays Capital Securities Ltd1.44%
August 14, 2026JPM Securities Japan Co Ltd.1.41%
August 13, 2026Barclays Capital Securities Ltd1.59%
August 13, 2026JPM Securities Japan Co Ltd.1.54%
August 10, 2026JPM Securities Japan Co Ltd.1.61%
August 7, 2026Nomura International plc2.57%
August 6, 2026Nomura International plc2.60%
August 5, 2026Nomura International plc2.53%

Download 55 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats

Other companies sold short in Japan

Cite this page

The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.

QuiVad, BrightPath Biotherapeutics Co.,Ltd., source JPX, data as at October 5, 2026, https://www.quivad.com/action/brightpath-biotherapeutics-co-ltd